
|Articles|December 1, 2004
New ventures may help make up for lost reimbursement
San Diego--Searching for ways to recoup lost revenue from outpatient prostate cancer therapy, urologists have turned to a variety of non-traditional income producers, ranging from CT scanning to processing of biopsy specimens.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












